You searched for: kelhom (Maltesiska - Engelska)

fir-reġistru pnh, pazjenti kkurati b’soliris ġew osservati li kelhom tnaqqis fl-emolisi u sintomi assoċjati.
in the pnh registry, patients treated with soliris were observed to have a reduction in haemolysis and associated symptoms.

il-ministri kelhom ukoll laqgħa informali waqt il-kolazzjon biex jiddiskutu l-qafas finanzjarju pluriennali 2014-2020 tal-ue.
ministers also held an informal breakfast meeting to discuss the eu's multiannual financial framework 2014-2020.

fi studju open-label randomised (apv30003) fuq pazjenti li kelhom l-impeditur protease b’falliment viroloġiku (inqas minn jew ugwali għal żewġ pis) fosamprenavir flimkien ma’ ritonavir (700/100 mg darbtejn kuljum jew 1400/200 mg darba kuljum) ma wrewx nuqqas ta’ non-inferjorità għal lopinavir / ritonavir fir-rigward ta’ soppressjoni virali kif imkejla mill-medja ta’ l-erja ta’ taħt il-kurva (aaucmb) għal hiv-1 rna fil-plażma matul 48 ġimgħa (l-end-point primarju).
in a randomised open-label study (apv30003) in protease inhibitor experienced patients with virological failure (less than or equal to two pis) the fosamprenavir with ritonavir combination (700 / 100 mg twice daily or 1400 / 200 mg once daily) did not demonstrate non-inferiority to lopinavir / ritonavir with regard to viral suppression as measured by the average area under the curve minus baseline (aaucmb) for plasma hiv-1 rna over 48 weeks (the primary end point).